Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last A$0.0060 AUD
Change Today -0.001 / -14.29%
Volume 2.1M
As of 1:10 AM 10/5/15 All times are local (Market data is delayed by at least 15 minutes).

analytica ltd (ALT) Snapshot

Previous Close
Day High
Day Low
52 Week High
10/20/14 - A$0.03
52 Week Low
08/25/15 - A$0.0050
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for ANALYTICA LTD (ALT)

Related News

No related news articles were found.

analytica ltd (ALT) Related Businessweek News

No Related Businessweek News Found

analytica ltd (ALT) Details

Analytica Limited designs, develops, and supplies medical devices in Australia. The company’s products include PeriCoach system, a home personal trainer device and app to manage and monitor pelvic floor exercises to help reduce or stop leaking, as well as treat other symptoms of pelvic floor weakness; and ELF2, a medical device that assists neurologist and rehabilitates treatment of muscular spasticity. It also offers the AutoStart Infusion System, which contains an enhanced float device that automatically restarts IV fluid flow following infused delivery of the predetermined amount of medication. The company is based in Brisbane, Australia.

analytica ltd (ALT) Top Compensated Officers

Chief Executive Officer
Total Annual Compensation: A$210.0K
Executive Chairman, Member of Audit & Risk Ma...
Total Annual Compensation: A$75.0K
Chief Financial Officer, Executive Director, ...
Total Annual Compensation: A$50.0K
Compensation as of Fiscal Year 2014.

analytica ltd (ALT) Key Developments

Analytica Appoints Thomas Lönngren as Non-Executive Director

Analytica has appointed Dr. Thomas Lönngren as Non-Executive Director effective 10 August 2015. Dr. Lönngren brings a wealth of knowledge to the board having had a distinguished career serving as top international regulator for over 25 years and lately working as strategic advisor and board member for pharmaceutical and medical device companies. Dr. Lönngren's current positions include Director and Founder of Pharma Executive Consulting Ltd. in London, Strategic Advisor at NDA Group in Sweden, Germany, UK and Cambridge, MA, US and Non-Executive Director of Global Kinetics Corporation in Australia.

Analytica Ltd. Reports Earnings Results for the Half Year Ended December 31, 2014

Analytica Ltd. reported earnings results for the half year ended December 31, 2014. For the period, the company reported sales revenue of AUD 4,859. Loss before income tax was AUD 1,923,938 compared to AUD 1,373,021 a year ago. Loss for the period was AUD 1,923,938 compared to AUD 1,373,021 a year ago. Basic and diluted loss per share was 0.21 cents compared to 0.23 cents a year ago. Net cash used in operating activities of AUD 1,865,112 compared to AUD 977,915 a year ago. Purchase of proerty, plant and equipment was AUD 42,102 compared to AUD 3,973 a year ago.

Analytica Ltd., Annual General Meeting, Nov 27, 2014

Analytica Ltd., Annual General Meeting, Nov 27, 2014., at 17:00 E. Australia Standard Time. Location: Endeavour 1 Room, Level 1, Christie Corporate, 320 Adelaide Street. Agenda: To receive and consider the financial report, director's report and independent audit report for the company and its controlled entities for the financial year ended 30 June 2014; to consider the adoption of the remuneration report; to approve Board changes; to approve ratification of April and October 2014 Placement; to consider approval of enhanced placement capacity.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ALT:AU A$0.01 AUD -0.001

ALT Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for ALT.
View Industry Companies

Industry Analysis


Industry Average

Valuation ALT Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 4.5x
Price/Book 13.5x
Price/Cash Flow NM Not Meaningful
TEV/Sales 6.1x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ANALYTICA LTD, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at